All Blogs

Jul 28, 2025

Sarcopenia, often dubbed the “silent muscle thief,” is a progressive loss of skeletal muscle mass and strength that typically begins after the age of 30, accelerating after 60. Affecting up to 50% of adults over 80, sarcopenia isn’t just about frailty—it’s linked to increased risks of falls, fractures, loss of inde...

Jul 24, 2025

Medtronic Secured CE Mark Approval for its Minimed™ 780G System, Extending its use to Insulin-Requiring Individuals With Diabetes, Including Children as Young as two Years old, Pregnant Women, and Patients with Type 2 Diabetes  On July 21, 2025, Medtronic plc., a global medical technology leader, secured th...

Jul 25, 2025

Kidney transplant rejection remains one of the most significant challenges in the field of organ transplantation, despite remarkable advances in surgical techniques and immunosuppressive therapies. Around 10–15% of kidney transplant recipients experience acute rejection episodes within the first year, which, if lef...

Jul 23, 2025

In today’s surgical landscape, precision and biological integration are becoming just as important as technical skill. Biosurgery represents this shift, a field at the intersection of Medtech and Diagnostics, where biocompatible materials and regenerative techniques are used to improve surgical outcomes. From seali...

Jul 21, 2025

Eight years after its founding, partly backed by AstraZeneca, Dizal Pharmaceuticals has secured its first FDA approval, receiving accelerated clearance for ZEGFROVY (sunvozertinib)—now the only FDA-approved oral therapy for a rare subset of non-small cell lung cancer (NSCLC). The treatment is indicated for U.S. ...

Jul 18, 2025

The treatment options for spinal cord injury remain limited, with few approved spinal cord injury therapies available. At present, STEMIRAC is the only approved SCI treatment, and it is offered exclusively in Japan. There is an urgent need for targeted solutions that can enhance patient outcomes and support functio...

Jul 17, 2025

Medtronic Secured CE Mark for LigaSure™ Technology Integration on Hugo™ Robotic-Assisted Surgery System, Paving the Way for the Future of Surgery  On July 15, 2025, Medtronic plc, a global leader in healthcare technology, announced that it received CE Mark approval for its LigaSure™ RAS vessel-sealing techn...

Jul 16, 2025

Medical tourism is rapidly transforming the global healthcare landscape, as more patients cross borders in search of affordable, high-quality treatments and timely care. Driven by the promise of advanced treatments, reduced costs, and shorter wait times, millions seek medical care in countries offering specialized ...

Jul 15, 2025

Nanoscope Therapeutics Begins FDA Rolling Submission for MCO-010 in Retinitis Pigmentosa Nanoscope Therapeutics has initiated a rolling submission of its Biologics License Application (BLA) to the FDA for MCO-010, a first-in-class, gene-agnostic optogenetic therapy targeting severe vision loss due to retinitis p...

Jul 14, 2025

Following an unexpected regulatory delay last month, KalVista Pharmaceuticals has officially entered the commercial market with the FDA approval of its plasma kallikrein inhibitor, sebetralstat. On July 7, 2025, the FDA cleared sebetralstat, now branded as EKTERLY, as an oral treatment for acute hereditary angioede...